Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(S)-dihydroorotate + acceptor
orotate + reduced acceptor
(S)-dihydroorotate + ferricyanide
orotate + ferrocyanide
(S)-dihydroorotate + fumarate
orotate + succinate
(S)-dihydroorotate + O2
orotate + H2O2
dihydroorotate + 2,3-dimethoxy-5-methyl-6-(3-methyl-2-butenyl)-1,4-benzoquinone
orotate + reduced 2,3-dimethoxy-5-methyl-6-(3-methyl-2-butenyl)-1,4-benzoquinone
-
-
-
?
dihydroorotate + 2,6-dichloroindophenol
orotate + reduced 2,6-dichloroindophenol
-
-
-
?
dihydroorotate + 2,6-dichlorophenolindophenol
orotate + ?
-
-
-
-
?
dihydroorotate + 2,6-dichlorophenolindophenol
orotate + reduced 2,6-dichlorophenolindophenol
dihydroorotate + acceptor
orotate + reduced acceptor
dihydroorotate + ferricyanide
orotate + ferrocyanide
-
-
-
-
?
dihydroorotate + fumarate
orotate + ?
dihydroorotate + fumarate
orotate + reduced fumarate
dihydroorotate + fumarate
orotate + succinate
-
prefers fumarate over ubiquinone-1
-
-
?
dihydroorotate + O2
orotate + H2O2
dihydroorotate + ubiquinone-1
orotate + ubiquinol-1
-
-
-
-
?
dihydrooxonate + acceptor
oxonate + reduced acceptor
L-dihydroorotate + 2,6-dichloroindophenol
orotate + ?
-
-
-
-
?
L-dihydroorotate + 2,6-dichlorophenolindophenol
orotate + reduced 2,6-dichlorophenolindophenol
-
-
-
-
?
L-dihydroorotate + CoQ
orotate + ?
-
-
-
-
?
L-dihydroorotate + crotonate
orotate + butanoate
-
-
-
-
?
L-dihydroorotate + fumarate
orotate + succinate
L-dihydroorotate + mesaconate
orotate + 2-methylbutanedioate
-
-
-
-
?
L-dihydroorotate + O2
orotate + H2O2
-
-
-
-
?
orotate + ferricyanide
(S)-dihydroorotate + ferrocyanide
S-dihydroorotate + 2,6-dichlorophenolindophenol
orotate + reduced 2,6-dichlorophenolindophenol
-
-
-
-
?
S-dihydroorotate + fumarate
orotate + succinate
-
100% activity
-
-
?
S-dihydroorotate + menadione
orotate + menadiol
-
20% activity with menadione compared to fumarate
-
-
?
additional information
?
-
(S)-dihydroorotate + acceptor

orotate + reduced acceptor
-
fumarate and ferricyanide tested as electron acceptors
-
?
(S)-dihydroorotate + acceptor
orotate + reduced acceptor
-
fumarate and ferricyanide tested as electron acceptors
-
?
(S)-dihydroorotate + acceptor
orotate + reduced acceptor
-
2,6-dichlorophenolindophenol, potassium hexacyanoferrate(III) and molecular oxygen used as electron acceptors
-
?
(S)-dihydroorotate + acceptor
orotate + reduced acceptor
-
fourth step in synthesis of pyrimidine nucleotides
-
?
(S)-dihydroorotate + acceptor
orotate + reduced acceptor
-
fourth step in UMP-biosynthesis
-
?
(S)-dihydroorotate + acceptor
orotate + reduced acceptor
-
preferred electron acceptors in the decreasing order: ferricyanide, 2,6-dichlorophenolindophenol, ubiquinone-0, fumarate and O2
-
?
(S)-dihydroorotate + acceptor
orotate + reduced acceptor
-
fourth step in synthesis of pyrimidine nucleotides
-
?
(S)-dihydroorotate + ferricyanide

orotate + ferrocyanide
-
-
-
?
(S)-dihydroorotate + ferricyanide
orotate + ferrocyanide
-
ferricyanide usually used as electon acceptor in the assay
-
?
(S)-dihydroorotate + fumarate

orotate + succinate
-
-
-
-
?
(S)-dihydroorotate + fumarate
orotate + succinate
-
-
-
-
?
(S)-dihydroorotate + fumarate
orotate + succinate
-
-
-
-
?
(S)-dihydroorotate + fumarate
orotate + succinate
-
-
-
-
ir
(S)-dihydroorotate + fumarate
orotate + succinate
-
-
-
?
(S)-dihydroorotate + fumarate
orotate + succinate
-
enzyme is responsible for biosynthesis of succinate and orotate
-
-
?
(S)-dihydroorotate + fumarate
orotate + succinate
-
-
-
?
(S)-dihydroorotate + O2

orotate + H2O2
-
ferricyanide, 2,6-dichlorophenolindophenol, cytochrome c and quinones as alternate electron acceptor, with ferricyanide 12 times faster rate of catalysis than with air alone
-
?
(S)-dihydroorotate + O2
orotate + H2O2
-
different dihydroorotate isotopes tested for mechanistic and stereochemical analysis
-
?
(S)-dihydroorotate + O2
orotate + H2O2
-
ferricyanide, cytochrome c and 2,6-dichlorophenolindolphenol as alternate electron acceptor
-
?
(S)-dihydroorotate + O2
orotate + H2O2
-
redox dyes, 2,6-dichlorophenolindophenol, ferricyanide are most active electron acceptors, oxygen and cytochrome c are much slower
-
?
(S)-dihydroorotate + O2
orotate + H2O2
-
pathway of pyrimidine biosynthesis, constitutive biosynthetic enzyme
-
?
(S)-dihydroorotate + O2
orotate + H2O2
-
pathway of pyrimidine biosynthesis, constitutive biosynthetic enzyme
-
?
(S)-dihydroorotate + O2
orotate + H2O2
-
ferricyanide as alternate electron acceptor, enzyme produced regardless of the carbon source
-
?
(S)-dihydroorotate + O2
orotate + H2O2
-
ferricyanide, 2,6-dichlorophenolindophenol, cytochrome c and quinones as alternate electron acceptor, with ferricyanide 12 times faster rate of catalysis than with air alone
-
?
(S)-dihydroorotate + O2
orotate + H2O2
-
ferricyanide, 2,6-dichlorophenolindophenol, cytochrome c and quinones as alternate electron acceptor, with ferricyanide 12 times faster rate of catalysis than with air alone
-
?
(S)-dihydroorotate + O2
orotate + H2O2
-
-
-
-
?
dihydroorotate + 2,6-dichlorophenolindophenol

orotate + reduced 2,6-dichlorophenolindophenol
-
-
-
-
?
dihydroorotate + 2,6-dichlorophenolindophenol
orotate + reduced 2,6-dichlorophenolindophenol
-
-
-
-
?
dihydroorotate + acceptor

orotate + reduced acceptor
-
acceptor: 2,6-dichlorophenolindophenol
-
-
?
dihydroorotate + acceptor
orotate + reduced acceptor
-
not acceptors: NAD+, NADP+, coenzymes Q6, Q10, K2
-
-
?
dihydroorotate + acceptor
orotate + reduced acceptor
-
discussion of substrate binding and catalytic mechanism
-
-
?
dihydroorotate + acceptor
orotate + reduced acceptor
-
no substrate: dihydrouracil
-
-
?
dihydroorotate + acceptor
orotate + reduced acceptor
-
acceptors: potassium hexacyanoferrate(III), to a lower extent molecular oxygen
-
-
?
dihydroorotate + acceptor
orotate + reduced acceptor
-
-
-
-
?
dihydroorotate + acceptor
orotate + reduced acceptor
-
acceptor: 2,6-dichlorophenolindophenol
-
-
?
dihydroorotate + acceptor
orotate + reduced acceptor
-
kinetic isotope effects
-
-
?
dihydroorotate + acceptor
orotate + reduced acceptor
-
acceptor: ferricyanide, coenzyme Q0, fumarate, molecular oxygen
-
-
?
dihydroorotate + fumarate

orotate + ?
-
-
-
?
dihydroorotate + fumarate
orotate + ?
-
-
-
-
?
dihydroorotate + fumarate
orotate + ?
-
-
-
?
dihydroorotate + fumarate
orotate + ?
-
-
-
-
?
dihydroorotate + fumarate
orotate + ?
-
-
-
?
dihydroorotate + fumarate

orotate + reduced fumarate
-
-
-
-
?
dihydroorotate + fumarate
orotate + reduced fumarate
-
-
-
-
?
dihydroorotate + fumarate
orotate + reduced fumarate
-
-
-
?
dihydroorotate + O2

orotate + H2O2
-
-
-
-
?
dihydroorotate + O2
orotate + H2O2
-
-
-
-
?
dihydroorotate + O2
orotate + H2O2
-
-
-
-
?
dihydrooxonate + acceptor

oxonate + reduced acceptor
-
fumarate and ferricyanide tested as electron acceptors
-
?
dihydrooxonate + acceptor
oxonate + reduced acceptor
-
fumarate and ferricyanide tested as electron acceptors
-
?
dihydrooxonate + acceptor
oxonate + reduced acceptor
-
-
-
?
L-dihydroorotate + fumarate

orotate + succinate
-
-
-
-
?
L-dihydroorotate + fumarate
orotate + succinate
-
-
-
-
?
L-dihydroorotate + fumarate
orotate + succinate
-
fumarate is the most effective electron acceptor
-
-
?
L-dihydroorotate + fumarate
orotate + succinate
-
-
-
-
?
L-dihydroorotate + fumarate
orotate + succinate
-
DHODH catalyzes a coupled redox reaction in which dihydroorotate is oxidized to orotate and fumarate is reduced to succinate
-
-
?
L-dihydroorotate + fumarate
orotate + succinate
-
-
-
-
?
orotate + ferricyanide

(S)-dihydroorotate + ferrocyanide
-
-
-
-
r
orotate + ferricyanide
(S)-dihydroorotate + ferrocyanide
-
-
-
-
?
additional information

?
-
-
three-dimensional active site structure, profile of interactions for molecular recognition, interaction of DHODH with orotate via residues Asn212, Asn284, Ser215, Phe149, Lys100, Gly148, Asn217, Asn145, and Thr285, overview
-
-
?
additional information
?
-
-
no acceptor: fumarate, NAD+, coenzymes ubiquinone-6, ubiquinone-10
-
-
?
additional information
?
-
-
maleate, glutaconate, cis-aconitate, trans-aconitate, and cinnamate do not function as electron acceptor
-
-
?
additional information
?
-
-
does not perform electron transfer to menaquinone, Q0, Q1, Q2, QD, O2, or to NAD+
-
-
?
additional information
?
-
-
enzyme has methylviologen-fumarate reductase activity
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
1,5-dihydrofuro[3,4-d]pyrimidine-2,4,7-trione
-
-
1-(1-naphthyl)-3-[2-(trifluoromethyl)phenyl]urea
-
50% inhibition at 0.0004 mM, wild type, 0.00034 mM, mutant R265A, above 0.2, mutant H185A
1-(2-methoxyphenyl)-3-(1-naphthyl)urea
-
50% inhibition at 0.00023 mM, wild type, 0.00024 mM, mutant R265A, 0.140, mutant H185A
1-(4-Chloro-phenyl)-1H-pyrazole-3,5-dicarboxylic acid 3-(4-methyl-benzylamide) 5-phenylamide
-
minimum inhibitory concentration 0.032 mg/ml
1-(4-Chloro-phenyl)-1H-pyrazole-3,5-dicarboxylic acid 3-benzylamide 5-(isobutyl-amide)
-
minimum inhibitory concentration above 0.064 mg/ml
1-(4-Chloro-phenyl)-1H-pyrazole-3,5-dicarboxylic acid 3-benzylamide 5-[(4-carbamoyl-phenyl)-amide]
-
minimum inhibitory concentration 0.008 mg/ml
1-(4-Chloro-phenyl)-1H-pyrazole-3,5-dicarboxylic acid 5-phenylamide 3-[(pyridin-3-ylmethyl)-amide]
-
minimum inhibitory concentration 0.00025 mg/ml
1-(4-Chloro-phenyl)-1H-pyrazole-3,5-dicarboxylic acid 5-[(4-piperidin-1-yl-phenyl)-amide] 3-[(pyridin-3-ylmethyl)-amide]
-
minimum inhibitory concentration 0.002 mg/ml
1-(4-chlorophenyl)-3-quinolin-8-ylurea
-
50% inhibition at 0.00078 mM, wild type, 0.002 mM, mutant R265A, above 0.4, mutant H185A
1-(4-Methoxy-phenyl)-1H-pyrazole-3,5-dicarboxylic acid 3-(isobutyl-amide) 5-[[4-(pyrrolidine-1-carbonyl)-phenyl]-amide]
-
minimum inhibitory concentration 0.064 mg/ml
1-(4-Methoxy-phenyl)-1H-pyrazole-3,5-dicarboxylic acid 3-benzhydryl-amide 5-benzylamide
-
minimum inhibitory concentration above 0.032 mg/ml
1-(4-Methoxy-phenyl)-1H-pyrazole-3,5-dicarboxylic acid 3-benzylamide 5-[[4-(pyrrolidine-1-carbonyl)-phenyl]-amide]
-
minimum inhibitory concentration 0.003 mg/ml
1-(4-Methoxy-phenyl)-1H-pyrazole-3,5-dicarboxylic acid 5-benzylamide 3-[[4-(pyrrolidine-1-carbonyl)-phenyl]-amide]
-
minimum inhibitory concentration above 0.032 mg/ml
1-(4-Methoxy-phenyl)-1H-pyrazole-3,5-dicarboxylic acid 5-phenylamide 3-[(pyridin-3-ylmethyl)-amide]
-
minimum inhibitory concentration 0.0005 mg/ml
1-(4-Methoxy-phenyl)-1H-pyrazole-3,5-dicarboxylic acid 5-[[4-(pyrrolidine-1-carbonyl)-phenyl]-amide] 3-[(tetrahydro-furan-2-yl)-amide]
-
minimum inhibitory concentration above 0.032 mg/ml
2,3-dihydrotriazolo[4,5-d]pyrimidine-5,7-dione
-
-
2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid
-
-
2-methyl-3-nitro-N-[3-(trifluoromethyl)phenyl]benzamide
-
50% inhibition at 0.00008 mM, wild type, 0.00037 mM, mutant R265A, 0.120, mutant H185A
2-methyl-N-1-naphthyl-3-nitrobenzamide
-
50% inhibition at 0.00008 mM, wild type, 0.00048 mM, mutant R265A, 0.180, mutant H185A
2-thioorotate
-
orotate analogue, 50% inhibition at 0.018 mM
4,6-dioxo-1,4,5,6-tetrahydro-1,3,5-triazine-2-carboxylic acid
-
-
5-amino-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid
-
-
5-aminoorotate
-
orotate analogue, 50% inhibition at 1.6 mM
5-bromoorotate
-
orotate analogue, 50% inhibition at 0.016 mM
5-fluoro-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid
-
-
5-Fluoroorotate
-
orotate analogue, 50% inhibition at 0.055 mM
5-nitro-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid
-
-
5-nitroorotate
-
orotate analogue, 50% inhibition at 0.076 mM
5-[(dimethylamino)methyl]-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid
-
-
7,9-dihydro-3H-purine-2,6,8-trione
-
-
Barbiturate
-
dead-end inhibitor, competitive with respect to (S)-dihydroorotate
butyl 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylate
-
-
leflunomide
-
cell line A20R resistant to leflunomide shows enhanced expression of enzyme to bypass the inhibitory effect, following long-time exposure, enzyme gene amplification can be assumed
Mercuric chloride
-
40% inhibition after 15 min at 0.000045 mM
methanol extract of brown algae Fucus evanescens
-
59% inhibition, noncompetitive
-
methanol extract of brown algae Pelvetia babingtonii
-
58% inhibition, noncompetitive
-
N-(2,4-dichlorophenyl)-2-naphthamide
-
50% inhibition at 0.00005 mM, wild type, 0.00008 mM, mutant R265A, above 0.05, mutant H185A
N-(2-fluorophenyl)naphthalene-2-carboxamide
-
50% inhibition at 0.00047 mM, wild type, 0.00030 mM, mutant R265A, 0.21, mutant H185A
N-(3,4-dichlorophenyl)-2-methyl-3-nitrobenzamide
-
50% inhibition at 0.00008 mM, wild type, 0.0028 mM, mutant R265A, 0.06, mutant H185A
N-(3,4-difluorophenyl)-2-methyl-3-nitrobenzamide
-
50% inhibition at 0.00026 mM, wild type, 0.00082 mM, mutant R265A, 0.25, mutant H185A
N-(3,5-dichlorophenyl)-2-methyl-3-nitrobenzamide
-
50% inhibition at 0.00002 mM, wild type, 0.0004 mM, mutant R265A, 0.13, mutant H185A
N-(3-bromophenyl)-2-methyl-3-nitrobenzamide
-
50% inhibition at 0.00006 mM, wild type, 0.0012 mM, mutant R265A, 0.140, mutant H185A
N-(3-chloro-4-fluorophenyl)-2-methyl-3-nitrobenzamide
-
50% inhibition at 0.0001 mM, wild type, 0.0005 mM, mutant R265A, 0.13, mutant H185A
N-(4-bromo-2-methylphenyl)-2-naphthamide
-
50% inhibition at 0.00005 mM, wild type, 0.00005 mM, mutant R265A, 0.57, mutant H185A
N3-benzyl-1-(4-chlorophenyl)-N5-phenyl-1H-pyrazole-3,5-dicarboxamide
-
minimum inhibitory concentration 0.000125 mg/ml
orotate methyl ester
-
orotate analogue, 50% inhibition at 0.71 mM
oxonate
crystallization data
oxonic acid
-
orotate analogue, 50% inhibition at 0.0099 mM
p-hydroxymercuribenzoate
-
98% inhibition after 5 min at 0.00227 mM
Salicylhydroxamic acid
-
weak inhibition, pH 9.0, 37°C
suramin
-
weak inhibition, pH 9.0, 37°C
Tiron
-
inhibits cytochrome c reduction and sulfite autoxidation
Uracil
-
orotate analogue, 50% inhibition at 2.5 mM
3,4-dihydroxybenzoate

-
-
3,4-dihydroxybenzoate
-
competitive inhibition at 1 mM
3,5-Dihydroxybenzoate

-
-
3,5-Dihydroxybenzoate
-
non-competitive inhibition at 1 mM
Orotate

-
-
Orotate
-
competitive to dihydroorotate in ferricyanide reduction assay
Orotate
-
competitive product inhibition
Orotate
-
competitive, with ferricyanide as electron acceptor
Orotate
competitively inhibits all three DHOD enzymes to a comparable level
additional information

-
inhibitor virtual screening, overview
-
additional information
-
markable sensitivity to sulfhydryl inhibitors
-
additional information
-
visible light is inactivating
-
additional information
brequinar and DPC-AE661100 have no effect, even at a concentration of 1 mM
-
additional information
-
brequinar and DPC-AE661100 have no effect, even at a concentration of 1 mM
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.